Status:

COMPLETED

Orthopilot Elite Post-Market Clinical Follow-Up

Lead Sponsor:

Aesculap AG

Conditions:

Degenerative Osteoarthritis

Rheumatoid Arthritis

Eligibility:

All Genders

18-80 years

Brief Summary

Prospective, multicenter, observational, comparative clinical trial on the equivalence of two different OrthoPilot® navigation system generations applied for computer-assisted total knee arthroplasty

Detailed Description

The study is designed as a prospective, non-interventional, multicenter, comparative cohort study. The product under investigation will be used in routine clinical practice and according to the author...

Eligibility Criteria

Inclusion

  • Inclusion: Inclusion Criteria:
  • Patients with indication for Total Knee Arthroplasty using the Aesculap OrthoPilot® navigation system and a corresponding primary implant
  • Dated and signed informed consent
  • Exclusion: Exclusion Criteria
  • Pregnancy
  • Patients \< 18 years
  • Patients unable to participate at the follow-up examination (physically, mentally)
  • Previous joint replacement at the indexed knee

Exclusion

    Key Trial Info

    Start Date :

    July 1 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    October 29 2022

    Estimated Enrollment :

    217 Patients enrolled

    Trial Details

    Trial ID

    NCT03817632

    Start Date

    July 1 2019

    End Date

    October 29 2022

    Last Update

    January 17 2023

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Universitätsklinikum Carl Gustav Carus

    Dresden, Germany, 01307

    2

    Uniklinikum Freiburg

    Freiburg im Breisgau, Germany, 79106

    3

    Schönkliniken Klinikum Eilbek

    Hamburg, Germany, 22081

    Orthopilot Elite Post-Market Clinical Follow-Up | DecenTrialz